Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett’s Esophagus?

The importance of Barrett’s esophagus lies in its potential for malignant conversion to invasive esophageal adenocarcinoma (EA), a cancer with an extremely poor prognosis. Although a relatively rare event, with a progression risk of <1 per 300 patients with nondysplastic Barrett’s per year,1Hvid-Jensen F. Pedersen L. Drewes A.M. et al.Incidence of adenocarcinoma among patients with Barrett's esophagus.N Engl J Med. 2011; 365: 1375-1383Crossref...